Medical affairs professionals are responsible for representing their organizations and clearly conveying important information. In some cases, they can also gather, interpret, and communicate relevant information. In a recent conversation with two medical affairs leaders, they discuss how medical […]
ICER to Consider Aetion RWE in Revision of Hereditary Angioedema Therapy Report
ICER (the Institute for Clinical and Economic Review) has announced its decision to utilize RWE (real world evidence) data in its evaluation of three therapies (lanadelumab, Haegarda, and Cinryze) for use in preventing hereditary angioedema attacks. It will revise its 2018 report based on these data […]
The Patient Side of Successful Drug Development
More and more, patient opinions are being considered when it comes to designing effective therapeutics and testing their efficacy. A new ebook focuses on when and how patient feedback should be obtained during the drug development pipeline. It includes insights from leading pharma professionals on […]
ICER Announces Final Evidence Report for FibroGen’s Roxadustat, Uncertainties Linger
ICER has released a final evidence report for roxadustat, along with policy recommendations. Cardiovascular risks were one of the concerns surrounding the drug, which is designed to treat anemia in the context of chronic kidney disease. CTAF (California Technology Assessment Forum) members voted […]
Whitepaper on Field Medical Engagement During the COVID-19 Pandemic
Following the annual MAPS (Medical Affairs Professional Society) meeting, select members formed a group to discuss key challenges related to medical affairs and Field Medical roles. Although the COVID-19 pandemic has led to substantial challenges when it comes to acquiring and retaining talent, some […]
Virtual ISPOR 2021 Prerelease Session on HTAs in Clinical Trial Design
ISPOR will take place virtually from May 17th to 20th. Prerelease sessions will be available beginning on April 21st and available until June 30th, along with recordings from the conference. In a prerelease session moderated by Dr. Donna Messner, President and CEO of the Center for Medical […]
Medical Affairs Podcast on Corporate Alliance Management
MAPS (Medical Affairs Professional Society) is offering an on-demand podcast featuring insight from professionals with experience as medical strategists, as MSLs (medical science liaisons), in pharma, and as independent consultants. Depending on the structure and size of an organization, the role of […]
Webinar on New Performance Metric for Medical Affairs: Share of Scientific Voice
MAPS (Medical Affairs Professional Society) is offering a webinar discussing SoSV (Share of Scientific Voice), a single metric used to characterize both performance metrics and scientific impact. This metric represents a significant advance in generating evidence and clearly conveying […]
Considerations and Challenges for RWD Include Data Matching and Security
HealthVerity discusses several challenges when it comes to using deidentified patient data. Although using patient information can provide unique insight, it can be time-consuming to wade through the different types and sources of RWD (real world data). At the same time, data security must remain a […]
ICER To Review Hypertrophic Cardiomyopathy Drug
ICER has announced its intention to review mavacamten, a drug for use in hypertrophic cardiomyopathy. The Draft Scoping Document is receiving comments from the public until April 29th while a CTAF (California Technology Assessment Forum) meeting will take place in October 2021. “The Institute for […]
MAPS Mentorship Program Seeking Medical Affairs Mentors and Mentees
MAPS (Medical Affairs Professional Society) is offering a second round of mentorship for 2021 following a successful first round. This round will take place between July 19th and December 10th. Medical affairs leaders are paired with early-career professionals to improve their knowledge, enhance and […]
AMCP Offers Two Virtual Corporate Training Events to Enhance Knowledge of Medicare and PIE Strategies
The AMCP (Academy of Managed Care Pharmacy) will offer two virtual events designed to address knowledge gaps for leaders in life sciences companies. The first event will take place on April 28th, from 1-5 PM ET and will cover the intricacies of the Medicare Star Rating program. The second training […]
Thomas Jefferson University Offers Health Data Science Program
The Jefferson College of Population Health (JCPH) offers a program in Health Data Science. It also offers a short webinar introducing population health concepts to clinicians and other healthcare professionals. Live and on-demand sessions are available for individuals seeking to learn more about […]
Healthcare Spending in Massachusetts Increases, Drug Spending Largest Source of Growth
Massachusetts healthcare spending increased for the second year. Pharmacy services, hospital inpatient, hospital outpatient, and physician services all increased in 2019. Notably, prescription drug spending increased by 7.2 percent in 2019, making it the largest area of growth. “Hospital […]
Using Supplier Data Effectively to Improve Organization Efficiency
Supplier data, including information related to purchasing, sourcing, and contracts, can be useful in the right circumstances, but often leads to widespread confusion. Knowing when and how to use such information requires some advance planning and discussion. Companies succeeding during the COVID-19 […]
AMWA, EMWA, and ISMPP Joint Statement Includes Stakeholder Checklist
The AMWA (American Medical Writers Association), the EMWA (European Medical Writers Association), and the ISMPP (International Society for Medical Publication Professionals) recently released a joint statement on maintaining integrity in scientific and medical writing, throughout the peer review […]
IQVIA Announces New Virtual Series on Making the Most of RWE
IQVIA has announced a four-session webcast series on the use of RWE (real world evidence) in drug development leading to regulatory approval. The first session will take place on Wednesday, April 21st at 10 AM EDT and will focus on key tools to maximize the impact of RWE. IQVIA leaders, including […]
Three Medical Writing Associations Issue Joint Statement on State of Peer Review Process, Highlight Rushed COVID-19 Publications
In a joint statement by the AMWA (American Medical Writers Association), the EMWA (European Medical Writers Association), and the ISMPP (International Society for Medical Publication Professionals), the organizations discuss widespread problems associated with the peer review process. Often, this […]
ICER Releases Evidence Report on Lupus Nephritis Drugs
ICER has published a new evidence report on two drugs for use in lupus nephritis patients. FDA-approved voclosporin and belimumab are of clinical interest given the limited number of treatment options for this disease. The report took into consideration patient outcomes, cost analysis, and benefits […]
Blue Shield of California Expands Network, Seeks to Improve Access to COVID-19 Vaccine
Blue Shield of California has expanded its network coverage to include 1200 COVID-19 vaccination sites. This move is expected to improve access to COVID-19 vaccines for individuals living in underserved communities. The payers goal is to administer more than 4 million vaccines per week in the coming […]
New PRA Toolkit Helps Researchers Identify Risks in Clinical Trials
Researchers of rare and orphan diseases face unique challenges when it comes to drug development. Enrolling in a clinical trial can lead to high costs for patients, as well as reliance on a caregiver or friend. PRA Health Sciences has developed a toolkit to help clinical trial sponsors identify weak […]
New Article Details Medicaid Challenges for Individuals Approaching Poverty Definition, Note Over $2000 Excess Spending
According to a new report, people who exceed income requirements for Medicaid eligibility are affected by over $2000 in out-of-pocket spending over two years, attend less healthcare appointments, and face lower rates of medication adherence. The authors strongly recommend expanding Medicaid […]
Webinar on Successful Gene Therapy Development
An on-demand webinar by Certara details how pharmaceutical companies can streamline their drug development process. Although gene therapy treatments are often accelerated due to unmet patient needs, post-clinical success and market access remain challenging. Speakers include Dr. Emily Jean Woodward, […]
IQVIA Acquires Remaining 40% of Q2 Solutions, $760 Million Deal
IQVIA had previously held 60% of Q2 Solutions and has since acquired the remaining 40% from Quest Diagnostics in a $760 million deal. Q2 Solutions leadership, structure, name, and employees are expected to remain unchanged. Q2 is a leading clinical laboratory services organization. According to […]
Whitepaper on Tailoring Your Novel Therapeutic to ICER Standards
ICER (the Institute for Clinical and Economic Review) is an independent nonprofit organization dedicated to the fair evaluation of prescription drugs and other therapeutics, including medical devices. In its evaluations, it takes into account not only a drug’s efficacy, but also its cost relative to […]
ICER Releases Evidence Report on Multiple Myeloma Therapies
ICER has released a new evidence report on CAR T-cell therapies to treat multiple myeloma. All three therapeutics (idecabtagene vicleucel, ciltacabtagene autoleucel, and belantamab mafodotin-blmf) target the BCMA (B-cell maturation antigen) in pre-treated patients who have not been successful with […]
Healthcare AI Market Expected to Exceed $107,797 Million by 2027
The use of AI (artificial intelligence) in the healthcare field, include robot assisted surgeries, is expected to grow from 2019 levels of $3991.23 million to over $107,797 million by 2027. A new report discusses major trends in the market along with important considerations that will impair growth. […]
Finding Success in the Virtual COVID-19 Meeting Landscape
Dr. Michael Broder, President of HEOR consultancy group PHAR, discusses how the COVID-19 pandemic has altered in-person meetings. While there are certainly challenges associated with meeting virtually, there are also some important upsides, especially when utilizing a modified Delphi method to […]
GeneMatters and Concert Genetics Partner to Offer Personalized Genetics Services
GeneMatters, a genetics software company, and Concert Genetics, a genetic testing management company, have announced a new partnership. Together, they will offer personalized genetics services in a clinical setting. This partnership is timely as the genetic counseling field has doubled in the past […]
Equitably Providing COVID-19 Vaccines to People Experiencing Homelessness
Abt Associates collaborated with HUD (the Department of Housing and Urban Development), the CDC (Centers for Disease Control, and local COCs (Continuums of Care) to prioritize people experiencing homelessness when it comes to COVID-19 vaccine access. The Abt Associates technical assistance team […]
